dm+d
414984009
Articles
Using opioids for pain relief during pregnancy
10 August 2022Opioid analgesics may be used at any stage of pregnancy at the lowest effective dose for the short-term relief of pain when other analgesics are not effective
Example medicines to prescribe by brand name in primary care
27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
An example oral opioid switch from morphine to oxycodone
14 September 2021An example worked scenario to support you when switching or advising on switching between morphine and other oral opioids in cancer and palliative care
Tool to calculate estimated dose equivalences of oral morphine to other oral opioids
14 September 2021Use our tool to obtain approximate dose equivalences of oral morphine to other oral opioids and help you calculate an estimated equivalent dose
Switching between oral morphine and other oral opioids in adult palliative cancer care patients
14 September 2021Switching between morphine and alternative opioids requires care and thoughtful application of a stepped process
Medicine Compliance Aid Stability
OxyNormNapp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
OxyNorm
Capsules - various strengths
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container. Protect from light
22 November 2022
OxycontinNapp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Oxycontin
Tablets f/c, m/r various strengths
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container. Protect from light.
22 November 2022
TarginactNapp Pharmaceuticals Ltd
Napp Pharmaceuticals Ltd
Targinact
Tablets f/c, m/r - various strengths
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container and protect from light
11 May 2015
Lactation Safety Information
Oral / Parenteral
Oral / Parenteral
Dihydrocodeine, Morphine or other appropriate analgesic
Includes combinations with naloxone
Dose-dependent sedation has occurred in breastfed infants
Doses greater than 40mg/day should be avoided in breast feeding mothers
Oxycodone elimination in young infants is both variable and decreased
Avoid in neonates and monitor young infants (see summary)
29 July 2020